BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12109133)

  • 21. Transduction of long-term-engrafting human hematopoietic stem cells by retroviral vectors.
    Porada CD; Tran ND; Almeida-Porada G; Glimp HA; Pixley JS; Zhao Y; Anderson WF; Zanjani ED
    Hum Gene Ther; 2002 May; 13(7):867-79. PubMed ID: 11975852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing retroviral gene expression for effective therapies.
    Antoniou MN; Skipper KA; Anakok O
    Hum Gene Ther; 2013 Apr; 24(4):363-74. PubMed ID: 23517535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained phenotypic correction of hemophilia a mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells.
    Moayeri M; Ramezani A; Morgan RA; Hawley TS; Hawley RG
    Mol Ther; 2004 Nov; 10(5):892-902. PubMed ID: 15509507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic stem cell gene therapy.
    Emery DW; Nishino T; Murata K; Fragkos M; Stamatoyannopoulos G
    Int J Hematol; 2002 Apr; 75(3):228-36. PubMed ID: 11999349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adeno-associated virus-mediated gene transfer in hematopoietic stem/ progenitor cells as a therapeutic tool.
    Zhong L; Zhao W; Wu J; Maina N; Han Z; Srivastava A
    Curr Gene Ther; 2006 Dec; 6(6):683-98. PubMed ID: 17168699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of gene therapy for blood disorders by gene transfer into haematopoietic stem cells.
    Karlsson S; Ooka A; Woods NB
    Haemophilia; 2002 May; 8(3):255-60. PubMed ID: 12010420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions.
    Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W
    Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells.
    Uchida N; Sutton RE; Friera AM; He D; Reitsma MJ; Chang WC; Veres G; Scollay R; Weissman IL
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11939-44. PubMed ID: 9751769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic manipulation of hematopoietic stem cells.
    Larochelle A; Dunbar CE
    Semin Hematol; 2004 Oct; 41(4):257-71. PubMed ID: 15508111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene transfer into hematopoietic progenitor and stem cells: progress and problems.
    Dunbar CE; Emmons RV
    Stem Cells; 1994 Nov; 12(6):563-76. PubMed ID: 7881358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic stem cell gene therapy: towards clinically significant gene transfer efficiency.
    Heim DA; Dunbar CE
    Immunol Rev; 2000 Dec; 178():29-38. PubMed ID: 11213804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of gene expression: implications for design of retrovirus vectors.
    Pannell D; Ellis J
    Rev Med Virol; 2001; 11(4):205-17. PubMed ID: 11479927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advancements in Hematopoietic Stem Cell Gene Therapy: A Journey of Progress for Viral Transduction.
    Giommetti A; Papanikolaou E
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
    Neschadim A; McCart JA; Keating A; Medin JA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retroviral vector-mediated gene transfer into hematopoietic cells: prospects and issues.
    Smith C
    J Hematother; 1992; 1(2):155-66. PubMed ID: 1365023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroviral vector-mediated gene therapy for metabolic diseases: an update.
    Ferry N; Pichard V; Sébastien Bony DA; Nguyen TH
    Curr Pharm Des; 2011; 17(24):2516-27. PubMed ID: 21774771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to insulate lentiviral vector-expressed transgenes.
    Ramezani A; Hawley RG
    Methods Mol Biol; 2010; 614():77-100. PubMed ID: 20225037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene delivery to hematopoietic stem cells using lentiviral vectors.
    Miyoshi H
    Methods Mol Biol; 2004; 246():429-38. PubMed ID: 14970608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retroviral transduction of murine and human hematopoietic progenitors and stem cells.
    Ciuculescu MF; Brendel C; Harris CE; Williams DA
    Methods Mol Biol; 2014; 1185():287-309. PubMed ID: 25062637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current advances in retroviral gene therapy.
    Yi Y; Noh MJ; Lee KH
    Curr Gene Ther; 2011 Jun; 11(3):218-28. PubMed ID: 21453283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.